Connect with us

Business

The latest on the coronavirus outbreak for Sept. 23

Published

 on

 

A coronavirus sniffer dog named E.T. receives a cuddle from trainer Anette Kare at the Helsinki airport in Vantaa, Finland, on Tuesday. E.T. is trained to detect arriving passengers with COVID-19. (Antti Aimo-Koivisto/Lehtikuva/AFP via Getty Images)

 

We looked at 120,000 confirmed COVID-19 cases in Canada. Here’s what we found 

The coronavirus has been confirmed in more than 146,600 people across the country since the first case was detected. CBC News has dug deep into the data collected by the Public Health Agency of Canada (PHAC) to examine how COVID-19, the illness caused by the virus, affects the young, the elderly, men and women in order to better understand what’s most likely to land you in hospital — or worse. The data contains details on 121,795 cases up to the first week of September.

Some of our findings:

CBC’s analysis reveals that since mid-August, infections among young people (under 30) have surged and now, after a summer of provincial reopenings and expanded testing, cumulatively outnumber the elderly. COVID-19 infections are also on the rise among the very youngest (under 20) as schools, colleges and universities reopen.

The 9,000 cases that list symptom details suggest that people with COVID-19 suffer differently depending on age and symptoms. Chills, sore throat and runny nose were reported more frequently among those under 50. Cough and fever were common among all age groups.

Close to 10 per cent of people who tested positive for coronavirus ended up in hospital, according to the cases tracked by PHAC. Two per cent of cases landed in intensive care units (ICU) across all ages but mostly among people over 50. In people admitted to hospital, shortness of breath and fever were more common symptoms, while headaches, sore throat and runny nose were seen more often in less severe cases.

More than 9,200 people have died in Canada with COVID-19. Of all confirmed infections in Canada, six per cent, or 9,274 cases, have been fatal, with the elderly hit the hardest. Only two people under 20 are known to have died from the disease so far. More women in Canada have died from COVID-19, especially in the 80+ age group, where they outnumber men. Outside that age group, more men are dying from the virus.

Click below to watch more from The National

A runny nose and sore throat can be symptoms of COVID-19, but they’re also common symptoms of a cold or flu. British Columbia has removed them from a list disqualifying children from in-class learning, calling it a minor symptom of coronavirus, while other provinces are considering following suit. 2:01

IN BRIEF

Trudeau to make rare address to the nation amid COVID-19 fight; throne speech promises more support for affected Canadians

Prime Minister Justin Trudeau will make a rare address to the nation Wednesday evening on the fight against COVID-19 as confirmed cases continue to climb in Canada. Trudeau is also expected to summarize the government’s plans laid out in the throne speech, which included a promise to extend emergency support to people affected by the pandemic.

Two of Trudeau’s rival party leaders, Conservative Leader Erin O’Toole and Bloc Québécois Leader Yves-François Blanchet, have tested positive for the virus and have been forced to delay their responses to the throne speech until their self-isolation periods have ended.

CBC News will carry Trudeau’s address at 6:30 p.m. ET, followed by analysis and reaction. Watch, listen and follow live on cbcnews.ca, the CBC News app, CBC TV, CBC News Network, CBC Gem and CBC Radio, as well as on YouTube, Facebook and Twitter.

Ontario to launch COVID-19 testing in pharmacies Friday

Ontario will begin offering COVID-19 testing in pharmacies Friday, beginning with up to 60 pharmacies around the province, Premier Doug Ford says. The testing will be available by appointment only, for those not experiencing symptoms of the virus, and is expected to roll out to further locations in the coming weeks, the province says.

In addition, three hospitals will be offering saliva testing starting this week. Those hospitals include Women’s College, Mount Sinai and University Health Network―Toronto Western Hospital. The saliva-based tests will at first be conducted alongside the usual nasal-pharyngeal testing to assess their accuracy, Health Minister Christine Elliott said at a news conference Wednesday.

The testing initiative is the second part of the government’s fall pandemic preparedness plan. The first piece involved purchasing millions of seasonal flu shots that the government is encouraging all residents to get.

“We have prepared for the worst,” Elliott said. The province has seen modelling of various scenarios including a slow burn of little peaks and valleys in the daily numbers to more dramatic increases, the minister said. Elliott said further details about those models will be unveiled as the province continues to roll out its fall plan.

120 active COVID-19 cases reported on First Nations reserves across Canada 

There are currently 120 active cases of COVID-19 on First Nations reserves across Canada, according to data from Indigenous Services Canada. New cases since last week were primarily reported in Alberta, British Columbia and Manitoba. One death was reported, bringing the total of deaths on-reserve from COVID-19 to 10.

There have been 616 cases of COVID-19 on First Nations reserves as of Sept. 21, as well as 51 hospitalizations. A total of 486 First Nations people have recovered. Cases on First Nations reserves reported per region as of Sept. 21:

  • British Columbia: 132
  • Alberta: 265
  • Saskatchewan: 96
  • Manitoba: 8
  • Ontario: 68
  • Quebec: 47

Read CBC Indigenous’s weekly roundup of COVID-19 news in Indigenous communities here. 


 

 

Stay informed with the latest COVID-19 data from Canada and around the world.

THE SCIENCE

Johnson & Johnson begins final phase of single-shot COVID-19 vaccine study

New Jersey-based drug conglomerate Johnson & Johnson is beginning a huge final study to try to prove if a single-dose COVID-19 vaccine can protect against the coronavirus, The Associated Press reports. The study starting Wednesday will be one of the world’s largest coronavirus vaccine studies so far, testing the shot in 60,000 volunteers in the United States, South Africa, Argentina, Brazil, Chile, Colombia, Mexico and Peru.

In August, Canada signed a deal with a subsidiary of Johnson & Johnson to secure up to 38 million doses of the company’s potential vaccine.

A handful of other vaccines in the U.S. — including shots made by Moderna Inc. and Pfizer Inc. — and some in other countries are already in final-stage testing. Hopes are high that answers about at least one candidate being tested in the U.S. could come by year’s end, maybe sooner.

Many vaccine specialists question whether the Food and Drug Administration (FDA) will move at a safe pace under intense pressure from the current U.S. administration. U.S. President Donald Trump has consistently presented a faster timeline for a new vaccine than experts say is adequate to fully test the candidates. On Wednesday, he tweeted a link to news about the new Johnson & Johnson vaccine study and said the FDA “must move quickly.”

“We feel cautiously optimistic that we will be able to have a safe and effective vaccine, although there is never a guarantee of that,” Dr. Anthony Fauci, infectious disease chief at the National Institutes of Health, told a Senate committee on Wednesday.

AND FINALLY…

Preserving your pandemic harvest? Start slow, say experts

 

In this file photo, pickling jars are seen at a culinary event in New York City in 2011. This year saw an explosion of interest in gardening as the pandemic forced people to stay closer to home. (Neilson Barnard/Getty Images for International Culinary Center Catering & Events)

 

Canadians who grew their own gardens this pandemic summer and are looking to try pickling their bounty for the first time should start small, says an Edmonton woman who has been canning for years.

“You don’t have to take the whole weekend,” said Johwanna Alleyne, who teaches canning courses and runs a pickling business in Edmonton called Mojo Jojo Pickles, which produces everything from ketchup to jelly and relish. “Start with single jars, like make one or two jars of something that you’re really proud of…. You’ll catch on pretty quickly.”

This year saw an explosion of interest in gardening as the pandemic forced people to stay closer to home. Similar to the early rush for toilet paper and flour, people are now facing a shortage of Mason jars used to preserve their homegrown fruits and veggies.

Alleyne said she’s certainly noticed people getting into canning and pickling for the first time this year. “I didn’t know that pickles were an essential service, but it seems like they are,” she told CBC Radio’s The Current. “I think we’ve all appreciated just slowing down a little bit. And fresh, real food and good flavour and the comfort of good flavours become really important.”

With pickling, the amount of acid in the jar and how you fill it is important, as is the processing time, said Alleyne. That’s because canning gone wrong can lead to spoilage or cause botulism. If jars meant to preserve peaches or nectarines aren’t prepared properly, for example, you may notice air bubbles, which will cause the preserved fruit to slowly spoil.

 

Source:- CBC.ca

Source link

Business

Copper hits $7,000 a tonne as ‘green-tinted’ rally hots up – Financial Times

Published

 on


Copper hit $7,000 a tonne for the first time since 2018 on Wednesday, as strong demand in China and hopes for a wave of “green” stimulus measures lift the price of the vital industrial metal. 

Benchmark copper prices trading on the London Metal Exchange reached as high as $7,034 in afternoon trading, their strongest level since June 2018. The metal, used in everything from air conditioning units to cars and power networks, has risen about 14 per cent this year, on the back of supply disruptions and China’s rapid recovery from the coronavirus pandemic.

Chinese president Xi Jinping’s pledge last month that the world’s second-largest economy would be carbon neutral by 2060 is expected to lead to a focus on renewable energy in the country’s next five-year plan, which starts in 2021. In the US, Democratic presidential candidate Joe Biden has promised a $2tn green energy and infrastructure plan if he wins the election next month. 

Copper is emerging as one of the key ways for investors to gain exposure to a rollout of more wind, solar, batteries and electric cars, due to the metal’s use in electric wiring. “We believe investor interest in gaining exposure to the ‘decarbonisation’ theme is on the verge of reaching fever pitch,” said Max Layton, an analyst at Citigroup. 

China’s move last month was a “massive fundamental shift” that would give a meaningful uplift to copper demand over the next two to five years, especially in China’s electricity grid, Mr Layton said.

Analysts at Goldman Sachs said metals such as copper could enter a “green-tinted bull market”.

Copper consumption in the automotive and power sectors is set to grow by 2.3m tonnes over the next five years, accounting for almost three-quarters of projected global demand growth, Mr Layton said. 

On average, an electric car contains more than three times as much copper as an internal combustion car. Copper is also used in wind turbines and to connect renewable sources of generation to the grid.

In anticipation of its rising demand, China, the world’s largest consumer of copper, has been stockpiling supplies of the metal this year, according to analysts at Macquarie. Vivienne Lloyd, an analyst at the bank, estimates that China could have stockpiled 800,000 tonnes of the metal, based on the difference between imports and production. A rise in the renminbi to a two-year high on Wednesday against the dollar also makes copper cheaper for Chinese buyers.

“We do not believe that China has over-imported refined copper in 2020,” said Nicholas Snowdon, an analyst at Goldman Sachs. “The surge in refined imports has been a necessary offset to sharp declines . . . resulting from disruptions in mine supply and scrap flows.”

Copper’s rally has also been boosted by supply interruptions due to Covid-19 restrictions on mining companies. Antofagasta, the Chilean copper miner, said on Wednesday that its third-quarter production fell 4.6 per cent in the three months to the end of September from the previous quarter. 

Supply could be under further pressure depending on the outcome of a constitutional referendum in Chile this Sunday. Chile is the world’s largest copper producer, from mines owned by BHP, Glencore, Anglo American and Antofagasta. Miners could face higher taxes or tighter controls on their rights over water if Chile’s constitution is rewritten, according to analysts. 

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Tech Stocks Are Crushing the Market This Year: Where to Invest $1,000 Today – The Motley Fool Canada

Published

 on


Even amid a global pandemic that continues to wreak havoc on economies across the globe, the Canadian market is down just 5% on the year — not too bad considering at one point the S&P/TSX Composite Index dropped more than 30% in a single month.

The market crash earlier this year was one of the steepest drops that Canadians had faced in decades. It’s very possible that the worst has yet to come, but investors have witnessed an incredible bounce back over the past seven months.

The previously mentioned index has run up close to 45% since the last week of March. But even as strong as that bull run has been, many tech stocks have surged far more than 45% over the past seven months.

Canadian tech favourites like Shopify and Lightspeed have seen their share prices explode since the market began to rebound. Since the beginning of April, both tech stocks are up more than 200%.

Why are tech stocks soaring?

The global pandemic has dramatically increased the dependence on technology for both consumers and businesses across the globe. The trend of shifting towards a digital world was already evident, the pandemic just helped accelerate that digitization. As a result, we’ve seen stocks critical to helping digitize a business, such as Shopify and Lightspeed, soar throughout this pandemic.

It’s not just popular stocks like Shopify and Lightspeed that are on incredible bull runs, though. There’s a long list of Canadian tech stocks that deserve serious consideration for any investor that’s willing to hold for the long term.

I’ve covered a tech stock that has absolutely crushed the Canadian market this year. In addition to that, I believe that this company has a very strong chance to continue to outperform the Canadian market over the next decade.

Docebo

The pandemic has altered the lives and routines of Canadians across the country — perhaps none bigger than the changes within the working environment. To respect social-distancing regulations, the percentage of employees working from home has skyrocketed this year. And the longer employees continue to do so, the harder it may be to return to the grind of the office commute.

Docebo (TSX:DCBO) is my top work-from-home stock. The tech company specializes in developing cloud-based learning platforms that provide a virtual training experience for employees. The technology is powered by artificial intelligence, aimed to develop a unique learning experience for each user.

The tech stock has been a public company for just over one year. It’s a short track record to review performance, but investors that picked up shares just about at any point over the past year would be sitting on gains today. 

Since the beginning of the year, the stock is up 215%. That’s not too bad considering the Canadian market is down 5%. But if you were fortunate to pick up shares at the lowest point of the year, you’d be up more than 400%. 

Valuation is my biggest knock against Docebo. Growth of more than 200% on the year doesn’t come without the risk of extreme levels of volatility.

The company trades today at a very expensive price-to-sales ratio of 30. It might seem high, but that’s the cost of investing in a company that has grown 400% over the seven months.

Foolish bottom line

Just because the market is down on the year doesn’t mean there aren’t any companies that are growing. The tech industry is full of stocks that are trading near all-time highs today.

If you’re able to hold for the long term and can stomach the highly anticipated volatility over the short term, this is one tech stock that has the potential to continue to outperform the market for a long time.

Looking for more market-beating tech stock ideas? Be sure to check this report…

Just Released! 5 Stocks Under $49 (FREE REPORT)

Motley Fool Canada‘s market-beating team has just released a brand-new FREE report revealing 5 “dirt cheap” stocks that you can buy today for under $49 a share.
Our team thinks these 5 stocks are critically undervalued, but more importantly, could potentially make Canadian investors who act quickly a fortune.
Don’t miss out! Simply click the link below to grab your free copy and discover all 5 of these stocks now.

Claim your FREE 5-stock report now!


Fool contributor Nicholas Dobroruka owns shares of Lightspeed POS Inc and Shopify. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of and recommends Shopify and Shopify. The Motley Fool owns shares of Lightspeed POS Inc.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

WestJet, Air Canada in Twitter fight over flight refunds – Yahoo Canada Finance

Published

 on


GlobeNewswire

Cell Surface Markers Market Research Report by Product, by Source, by Cell Type, by Application, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19

Cell Surface Markers Market Research Report by Product (Antibodies and Pcr Arrays), by Source (Mice and Rats), by Cell Type, by Application, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19New York, Oct. 23, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Cell Surface Markers Market Research Report by Product, by Source, by Cell Type, by Application, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19” – https://www.reportlinker.com/p05913780/?utm_source=GNW The Global Cell Surface Markers Market is expected to grow from USD 561.02 Million in 2019 to USD 903.48 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.26%. Market Segmentation & Coverage: This research report categorizes the Cell Surface Markers to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Product, the Cell Surface Markers Market studied across Antibodies and Pcr Arrays. Based on Source, the Cell Surface Markers Market studied across Mice and Rats. Based on Cell Type, the Cell Surface Markers Market studied across B Cell Surface Markers, Monocyte Cell Surface Markers, NK Cell Surface Markers, and T Cell Surface Markers. Based on Application, the Cell Surface Markers Market studied across Clinical and Research. The Clinical further studied across Immunodeficiency Diseases and Oncology. The Research further studied across Drug Discovery, Immunology, and Stem Cell Research. Based on End User, the Cell Surface Markers Market studied across Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, and Pharmaceutical & Biotechnology Companies. Based on Geography, the Cell Surface Markers Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Surface Markers Market including Abcam, Becton, Dickinson and Company, Bio-Rad Laboratories, Bio-Techne, Biolegend, Cell Signaling Technology, Danaher Corporation, F. Hoffman-La Roche, Genscript, Merk KGaA, Qiagen N.V., and Thermo Fisher Scientific. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Surface Markers Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth. Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments The report answers questions such as: 1. What is the market size and forecast of the Global Cell Surface Markers Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Surface Markers Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Surface Markers Market? 4. What is the competitive strategic window for opportunities in the Global Cell Surface Markers Market? 5. What are the technology trends and regulatory frameworks in the Global Cell Surface Markers Market? 6. What are the modes and strategic moves considered suitable for entering the Global Cell Surface Markers Market? Read the full report: https://www.reportlinker.com/p05913780/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place. __________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Let’s block ads! (Why?)



Source link

Continue Reading

Trending